Phenome-wide Mendelian randomisation analysis identifies causal factors for age-related macular degeneration
- PMID: 36705323
- PMCID: PMC9883012
- DOI: 10.7554/eLife.82546
Phenome-wide Mendelian randomisation analysis identifies causal factors for age-related macular degeneration
Abstract
Background: Age-related macular degeneration (AMD) is a leading cause of blindness in the industrialised world and is projected to affect >280 million people worldwide by 2040. Aiming to identify causal factors and potential therapeutic targets for this common condition, we designed and undertook a phenome-wide Mendelian randomisation (MR) study.
Methods: We evaluated the effect of 4591 exposure traits on early AMD using univariable MR. Statistically significant results were explored further using: validation in an advanced AMD cohort; MR Bayesian model averaging (MR-BMA); and multivariable MR.
Results: Overall, 44 traits were found to be putatively causal for early AMD in univariable analysis. Serum proteins that were found to have significant relationships with AMD included S100-A5 (odds ratio [OR] = 1.07, p-value = 6.80E-06), cathepsin F (OR = 1.10, p-value = 7.16E-05), and serine palmitoyltransferase 2 (OR = 0.86, p-value = 1.00E-03). Univariable MR analysis also supported roles for complement and immune cell traits. Although numerous lipid traits were found to be significantly related to AMD, MR-BMA suggested a driving causal role for serum sphingomyelin (marginal inclusion probability [MIP] = 0.76; model-averaged causal estimate [MACE] = 0.29).
Conclusions: The results of this MR study support several putative causal factors for AMD and highlight avenues for future translational research.
Funding: This project was funded by the Wellcome Trust (224643/Z/21/Z; 200990/Z/16/Z); the University of Manchester's Wellcome Institutional Strategic Support Fund (Wellcome ISSF) grant (204796/Z/16/Z); the UK National Institute for Health Research (NIHR) Academic Clinical Fellow and Clinical Lecturer Programmes; Retina UK and Fight for Sight (GR586); the Australian National Health and Medical Research Council (NHMRC) (1150144).
Keywords: AMD; Mendelian randomisation; Mendelian randomization; age-related macular degeneration; causal inference; human; macular degeneration; medicine; statistics.
© 2023, Julian et al.
Conflict of interest statement
TJ, JC, HG, ES, GB, PS No competing interests declared, SM Cofounder of Seonix Bio Ltd; holds stock in Seonix Bio Ltd, TA Involved in advisory boards and has received grants and speaker fees from Allergan, Novartis, Bayer, Roche, Bausch and Lomb, Heidelberg, Topcon and Canon; received consulting fees from Thea Pharmaceuticals
Figures
Similar articles
-
The causal effects of lifestyle, circulating, pigment, and metabolic factors on early age-related macular degeneration: a comprehensive Mendelian randomization study.J Transl Med. 2024 Nov 1;22(1):988. doi: 10.1186/s12967-024-05773-9. J Transl Med. 2024. PMID: 39482668 Free PMC article.
-
Lack of bidirectional association between age-related macular degeneration and Alzheimer's disease: A Mendelian randomization study.Alzheimers Dement. 2022 Dec;18(12):2725-2729. doi: 10.1002/alz.12775. Epub 2022 Aug 25. Alzheimers Dement. 2022. PMID: 36016508
-
Role of plasma fatty acid in age-related macular degeneration: insights from a mendelian randomization analysis.Lipids Health Dis. 2024 Jun 29;23(1):206. doi: 10.1186/s12944-024-02197-8. Lipids Health Dis. 2024. PMID: 38951820 Free PMC article.
-
Causal inference on neuroimaging data with Mendelian randomisation.Neuroimage. 2022 Sep;258:119385. doi: 10.1016/j.neuroimage.2022.119385. Epub 2022 Jun 14. Neuroimage. 2022. PMID: 35714886 Free PMC article. Review.
-
CRISPR Manipulation of Age-Related Macular Degeneration Haplotypes in the Complement System: Potential Future Therapeutic Applications/Avenues.Int J Mol Sci. 2024 Jan 30;25(3):1697. doi: 10.3390/ijms25031697. Int J Mol Sci. 2024. PMID: 38338978 Free PMC article. Review.
Cited by
-
Genetic associations between circulating immune cells and periodontitis highlight the prospect of systemic immunoregulation in periodontal care.Elife. 2024 Mar 27;12:RP92895. doi: 10.7554/eLife.92895. Elife. 2024. PMID: 38536078 Free PMC article.
-
Mendelian Randomization Study With Clinical Follow-Up Links Metabolites to Risk and Severity of Pulmonary Arterial Hypertension.J Am Heart Assoc. 2024 Mar 19;13(6):e032256. doi: 10.1161/JAHA.123.032256. Epub 2024 Mar 8. J Am Heart Assoc. 2024. PMID: 38456412 Free PMC article.
-
Vitamin D levels and risk of ocular disorders: insights from bidirectional and multivariable Mendelian randomization analysis.Front Med (Lausanne). 2024 Oct 9;11:1431170. doi: 10.3389/fmed.2024.1431170. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39444820 Free PMC article.
-
Decreased Circulating Very Small Low-Density Lipoprotein is Likely Causal for Age-Related Macular Degeneration.Ophthalmol Sci. 2024 Apr 22;4(5):100535. doi: 10.1016/j.xops.2024.100535. eCollection 2024 Sep-Oct. Ophthalmol Sci. 2024. PMID: 39091897 Free PMC article.
-
Genetically defined causal effects of natural killer cells related traits in risk of infection: a Mendelian randomization study.BMC Infect Dis. 2024 Sep 17;24(1):986. doi: 10.1186/s12879-024-09890-0. BMC Infect Dis. 2024. PMID: 39289620 Free PMC article.
References
-
- Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. 1995;57:289–300. doi: 10.1111/j.2517-6161.1995.tb02031.x. - DOI
-
- Boddy S, Islam M, Moll T, Kurz J, Burrows D, McGown A, Bhargava A, Julian TH, Harvey C, Marshall JNG, Hall BPC, Allen SP, Kenna KP, Sanderson E, Zhang S, Ramesh T, Snyder MP, Shaw PJ, McDermott C, Cooper-Knock J. Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis. Brain Communications. 2022;4:fcac069. doi: 10.1093/braincomms/fcac069. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
